The firm is advising Omnicare, Inc. (NYSE: OCR) on its proposed acquisition of PharMerica Corporation (NYSE: PMC) for US$15 per share of PharMerica common stock. The proposed transaction is valued at approximately US$716 million.
Dewey & LeBoeuf has previously advised Omnicare on a number of significant transactions, including Omnicare’s $1.8 billion unsolicited acquisition of NeighborCare and $460 million unsolicited acquisition of NCS Healthcare.
The Dewey & LeBoeuf team is being led by Partner Mort Pierce, working with Partner Chang-Do Gong.